A Phase I Clinical Trial of Bevacizumab Injection

Clinical trial NCT05476341 · COMPLETED

Trial details

NCT number: NCT05476341
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rectal Cancer Lung Cancer Ovarian Cancer Cervical Cancer Glioblastoma

Start date: 2017-04-06
Primary completion: 2017-08-18
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.